Therapeutic vulnerabilities exposed by the 9p21 loss identified through multiparametric drug screening inform rational combination strategies

Abstract Homozygous loss of the 9p21 locus encompassing CDKN2A, CDKN2B, and MTAP is the most frequent copy number alteration across tumor types, making it a promising target for precision medicine strategies. To explore drug vulnerabilities exposed by this loss, we generated 9p21 locus isogenic blad...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Riccardo Bevilacqua, Paola Gasperini, Thomas Cantore, Catarina Macedo-Silva, Michael Pancher, Martina Radić, Haiyan Yue, Orsetta Quaini, Tarcisio Fedrizzi, Pamela Gatto, Roland Seiler, Bernhard Kiss, Valentina Adami, Francesca Lorenzin, Marianna Kruithof-de Julio, Bishoy Morris Faltas, Francesca Demichelis
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Nature Portfolio 2026-04-01
Seri Bilgileri:	npj Precision Oncology
Online Erişim:	https://doi.org/10.1038/s41698-026-01434-w
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Therapeutic vulnerabilities exposed by the 9p21 loss identified through multiparametric drug screening inform rational combination strategies

Benzer Materyaller